Magnetic nanoparticles of Fe₃O₄ enhance docetaxel-induced prostate cancer cell death

References

• JemalASiegelRXuJWardECancer statistics, 2010CA Cancer J Clin201060527730020610543
   PubMed Web of Science ®Google Scholar
• TabataNOhnoYMatsuiRPartial cancer prevalence in Japan up to 2020: estimates based on incidence and survival data from population-based cancer registriesJpn J Clin Oncol200838214615718245517
   PubMed Web of Science ®Google Scholar
• SoAGleaveMHurtado-ColANelsonCMechanisms of the development of androgen independence in prostate cancerWorld J Urol20052311915770516
   PubMed Web of Science ®Google Scholar
• DiazMPattersonSGManagement of androgen-independent prostate cancerCancer Control200411636437315625524
   PubMedGoogle Scholar
• LassiKDawsonNAUpdate on castrate-resistant prostate cancer: 2010Curr Opin Oncol201022326326720177381
   PubMed Web of Science ®Google Scholar
• TannockIFde WitRBerryWRTAX 327 InvestigatorsDocetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancerN Engl J Med2004351151502151215470213
   PubMed Web of Science ®Google Scholar
• PetrylakDPTangenCMHussainMHDocetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancerN Engl J Med2004351151513152015470214
   PubMed Web of Science ®Google Scholar
• NiraulaSTannockIFBroadening horizons in medical management of prostate cancerActa Oncol201150Suppl 114114721604955
   PubMed Web of Science ®Google Scholar
• LeeSYChoJSYukDYObovatol enhances docetaxel-induced prostate and colon cancer cell death through inactivation of nuclear transcription factor-kappaBJ Pharmacol Sci2009111212413619834284
   PubMed Web of Science ®Google Scholar
• MisraRAcharyaSSahooSKCancer nanotechnology: application of nanotechnology in cancer therapyDrug Discov Today20101519–2084285020727417
   PubMed Web of Science ®Google Scholar
• ShubayevVIPisanicTR2ndJinSMagnetic nanoparticles for theragnosticsAdv Drug Deliv Rev200961646747719389434
   PubMed Web of Science ®Google Scholar
• ChengJWuWChenBAEffect of magnetic nanoparticles of Fe3O4 and 5-bromotetrandrine on reversal of multidrug resistance in K562/A02 leukemic cellsInt J Nanomedicine2009420921619918367
   PubMed Web of Science ®Google Scholar
• WangCZhangHChenBYinHWangWStudy of the enhanced anticancer efficacy of gambogic acid on Capan-1 pancreatic cancer cells when mediated via magnetic Fe3O4 nanoparticlesInt J Nanomedicine201161929193521931488
   PubMed Web of Science ®Google Scholar
• ZhangGDingLRenegarRHydroxycamptothecin-loaded Fe3O4 nanoparticles induce human lung cancer cell apoptosis through caspase-8 pathway activation and disrupt tight junctionsCancer Sci201110261216122221435100
   PubMed Web of Science ®Google Scholar
• SatoATamuraYSatoNMelanoma-targeted chemo-thermo-immuno (CTI)-therapy using N-propionyl-4-S-cysteaminylphenol-magnetite nanoparticles elicits CTL response via heat shock protein-peptide complex releaseCancer Sci201010191939194620594194
   PubMed Web of Science ®Google Scholar
• KawaiKLiYSKasaiHAccurate measurement of 8-OH-dG and 8-OH-Gua in mouse DNA, urine and serum: effects of X-ray irradiationGenes and Environment2007293107114
   Google Scholar
• GalskyMDVogelzangNJDocetaxel-based combination therapy for castration-resistant prostate cancerAnn Oncol201021112135214420351071
   PubMed Web of Science ®Google Scholar
• HaradaMIwataCSaitoHNC-6301, a polymeric micelle rationally optimized for effective release of docetaxel, is potent but is less toxic than native docetaxel in vivoInt J Nanomedicine201272713272722745540
   PubMed Web of Science ®Google Scholar
• RenYZhangHChenBMultifunctional magnetic Fe3O4 nanoparticles combined with chemotherapy and hyperthermia to overcome multidrug resistanceInt J Nanomedicine201272261226922619560
   PubMed Web of Science ®Google Scholar
• AljarrahKMhaidatNMAl-AkhrasMAMagnetic nanoparticles sensitize MCF-7 breast cancer cells to doxorubicin-induced apoptosisWorld J Surg Oncol2012106222533492
   PubMed Web of Science ®Google Scholar
• KarlssonHLCronholmPGustafssonJMöllerLCopper oxide nanoparticles are highly toxic: a comparison between metal oxide nanoparticles and carbon nanotubesChem Res Toxicol20082191726173218710264
   PubMed Web of Science ®Google Scholar
• MaPLuoQChenJIntraperitoneal injection of magnetic Fe3O4-nanoparticle induces hepatic and renal tissue injury via oxidative stress in miceInt J Nanomedicine201274809481822973100
   PubMed Web of Science ®Google Scholar
• HussainSMHessKLGearhartJMGeissKTSchlagerJJIn vitro toxicity of nanoparticles in BRL 3A rat liver cellsToxicol In Vitro200519797598316125895
   PubMed Web of Science ®Google Scholar
• NaqviSSamimMAbdinMConcentration-dependent toxicity of iron oxide nanoparticles mediated by increased oxidative stressInt J Nanomedicine2010598398921187917
   PubMed Web of Science ®Google Scholar
• WangJYiJCancer cell killing via ROS: to increase or decrease, that is the questionCancer Biol Ther20087121875188418981733
   PubMed Web of Science ®Google Scholar
• ChenYWangJFraigMMDefects of DNA mismatch repair in human prostate cancerCancer Res200161104112412111358834
   PubMed Web of Science ®Google Scholar
• TrzeciakARNyagaSGJarugaPLohaniADizdarogluMEvansMKCellular repair of oxidatively induced DNA base lesions is defective in prostate cancer cell lines, PC-3 and DU-145Carcinogenesis20042581359137015044326
   PubMed Web of Science ®Google Scholar
• ChaiswingLBourdeau-HellerJMZhongWOberleyTDCharacterization of redox state of two human prostate carcinoma cell lines with different degrees of aggressivenessFree Radic Biol Med200743220221517603930
   PubMed Web of Science ®Google Scholar
• GasparianAVGuryanovaOAChebotaevDVShishkinAAYemelyanovAYBudunovaIVTargeting transcription factor NFkappaB: comparative analysis of proteasome and IKK inhibitorsCell Cycle20098101559156619372735
   PubMed Web of Science ®Google Scholar
• JainGCronauerMVSchraderMMöllerPMarienfeldRBNF-κB signaling in prostate cancer: a promising therapeutic target?World J Urol201230330331022085980
   PubMed Web of Science ®Google Scholar
• KoumakpayiIHLe PageCMes-MassonAMSaadFHierarchical clustering of immunohistochemical analysis of the activated ErbB/PI3K/Akt/NF-kappaB signalling pathway and prognostic significance in prostate cancerBr J Cancer201010271163117320216540
   PubMed Web of Science ®Google Scholar
• MacKenzieLMcCallPHatziieremiaSNuclear factor κB predicts poor outcome in patients with hormone-naive prostate cancer with high nuclear androgen receptorHum Pathol20124391491150022406367
   PubMed Web of Science ®Google Scholar
• JingHWangJYangPKeXXiaGChenBMagnetic Fe3O4 nanoparticles and chemotherapy agents interact synergistically to induce apoptosis in lymphoma cellsInt J Nanomedicine20105999100421187919
   PubMed Web of Science ®Google Scholar
• MaranoFHussainSRodrigues-LimaFBaeza-SquibanABolandSNanoparticles: molecular targets and cell signallingArch Toxicol201185773374120502881
   PubMed Web of Science ®Google Scholar